| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | PLAZ-14 | Treatment:Control | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-20 | Treatment:Control | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-23 | Treatment:Control | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-31 | Treatment:Control | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-32 | Treatment:Control | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-33 | Treatment:Control | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-01 | Treatment:Control | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-05 | Treatment:Control | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-11 | Treatment:Control | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-12 | Treatment:Control | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-29 | Treatment:Control | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-30 | Treatment:Control | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-04 | Treatment:Control | Day:Day 8 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-08 | Treatment:Control | Day:Day 8 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-15 | Treatment:Control | Day:Day 8 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-17 | Treatment:Control | Day:Day 8 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-18 | Treatment:Control | Day:Day 8 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-34 | Treatment:Control | Day:Day 8 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-22 | Treatment:Pravastatin | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-24 | Treatment:Pravastatin | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-36 | Treatment:Pravastatin | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-03 | Treatment:Pravastatin | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-16 | Treatment:Pravastatin | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-28 | Treatment:Pravastatin | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-02 | Treatment:Pravastatin | Day:Day 8 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-07 Rep Avg. | Treatment:Pravastatin | Day:Day 8 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-27 | Treatment:Pravastatin | Day:Day 8 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-09 | Treatment:Simvastatin | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-19 | Treatment:Simvastatin | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-26 | Treatment:Simvastatin | Day:Day 0 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-10 | Treatment:Simvastatin | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-21 | Treatment:Simvastatin | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-35 | Treatment:Simvastatin | Day:Day 12 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-06 Rep Avg. | Treatment:Simvastatin | Day:Day 8 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-13 | Treatment:Simvastatin | Day:Day 8 | nM |
| Reversed phase NEGATIVE ION MODE | PLAZ-25 | Treatment:Simvastatin | Day:Day 8 | nM |
Return to study ST000845 main page
Download data matrix(Statin Immuno-Metabolomics in Asthma (part III) Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|